Information Library
Case Studies - Clinical and marketing materials
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Chemotherapy launch in the US
September 23, 2009
This major pharma company managed to meet all its market milestones thanks to a comprehensive fast track education program in toxicity management - spanning medical and radiation oncology nurses and infusion centre personnel. -
Cardiovascular management in the UK
September 23, 2009
This case study reviews how a Primary Care Trust used a combination of social marketing and Nurse Advisors to bring cardiovascular care to local communities. -
Rheumatoid Arthritis in Germany
September 23, 2009
This program looks at how a major US pharmaceutical company used a nurse advisor program starting in 2009 to train patients to self-administer injections by syringe or pen. -
Controlling Diabetes in Spain
September 23, 2009
Spain has a real problem with diabetes: up to 10% of the population has the disease and it’s a killer, representing the 3rd highest cause of death amongst women. -
Asthma controlled in Poland
September 23, 2009
This case study reviews a 2007 pilot program using nurse advisors to identify patients with uncontrolled asthma in Poland. -
Post-Marketing Commitment Study
June 30, 2009
Quintiles developed creative and effective solutions to deliver quality data, cost efficiently and ahead of schedule. -
QT Population Modeling and Simulation Case Study
June 15, 2009
The importance of determining the most strategic Phase I/IIa study conducted by leading specialists shouldn’t be understated. Gain insight into QT and Population Modeling & Simulation. -
Harnessing a Speciality Salesforce
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, committed more than $400 million in milestone payments and sales force services to fund the launch of Cymbalta and support commercialization efforts for five years. A dedicated service company created by PharmaBio Development is providing more than 500 Innovex sales representatives to supplement the extensive Lilly primary care and specialty sales forces. -
How to Keep All Your Licenses in Compliance
March 25, 2009
Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses. -
Maneuvering a Drifting Project Back on Course
March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.
Page 1 of 1 (10 items)